Intercure Ltd. (INCR) reporting calendar
Intercure Ltd. files periodic reports with the SEC as INCR on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 30 Apr 2026
- Reports on record
- 5
Open INCR market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 30 Apr 2026 | 120 days | 0001493152-26-020743 |
| 20-F | 31 Dec 2024 | 1 May 2025 | 121 days | 0001641172-25-007971 |
| 20-F | 31 Dec 2023 | 1 May 2024 | 122 days | 0001493152-24-017348 |
| 20-F | 31 Dec 2022 | 1 May 2023 | 121 days | 0001493152-23-015012 |
| 20-F | 31 Dec 2021 | 28 Apr 2022 | 118 days | 0001493152-22-011405 |
Source: SEC EDGAR company submissions for CIK 0001857030. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.